• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清阳性血清中的一种1型人类免疫缺陷病毒(HIV-1)感染增强因子。

A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera.

作者信息

Robinson W E, Montefiori D C, Mitchell W M

机构信息

Vanderbilt University School of Medicine, Department of Pathology, Nashville, TN 37232.

出版信息

Biochem Biophys Res Commun. 1987 Dec 16;149(2):693-9. doi: 10.1016/0006-291x(87)90423-2.

DOI:10.1016/0006-291x(87)90423-2
PMID:3426595
Abstract

While testing sera for Human Immunodeficiency Virus neutralizing antibody titers, three sera were identified which had the ability to enhance infectivity of the virus. The sera were from three different individuals residing in Nashville, TN. The enhancing factor was not removed by either filtration through 0.05 micron filters or by incubation for one hour with a stoichiometric amount of protein A sepharose. Two of the sera were able to enhance infection by two divergent isolates (HTLV-IIIB and HTLV-IIIRF) while one was only capable of enhancing infection of target cells by HTLV-IIIB. None of the sera induced syncytium formation in chronic HIV-infected cells. The findings suggest that the substance is neither a virus nor an IgG class 1 or 2.

摘要

在检测人免疫缺陷病毒中和抗体滴度的血清时,发现三份血清具有增强病毒感染性的能力。这些血清来自田纳西州纳什维尔市的三名不同个体。增强因子既不能通过0.05微米滤器过滤去除,也不能与化学计量的蛋白A琼脂糖孵育一小时来去除。其中两份血清能够增强两种不同分离株(HTLV-IIIB和HTLV-IIIRF)的感染,而另一份血清仅能增强HTLV-IIIB对靶细胞的感染。这些血清均未在慢性HIV感染细胞中诱导合胞体形成。研究结果表明,该物质既不是病毒,也不是IgG 1类或2类。

相似文献

1
A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera.血清阳性血清中的一种1型人类免疫缺陷病毒(HIV-1)感染增强因子。
Biochem Biophys Res Commun. 1987 Dec 16;149(2):693-9. doi: 10.1016/0006-291x(87)90423-2.
2
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.用人免疫缺陷病毒env编码的合成肽抗体进行型特异性中和
Proc Natl Acad Sci U S A. 1988 Mar;85(6):1932-6. doi: 10.1073/pnas.85.6.1932.
3
Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.来自HIV血清阳性个体的抗GP 120抗体介导广泛反应性抗HIV ADCC。
AIDS Res Hum Retroviruses. 1987;3(4):409-22. doi: 10.1089/aid.1987.3.409.
4
Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.
Lancet. 1988 Apr 9;1(8589):790-4. doi: 10.1016/s0140-6736(88)91657-1.
5
Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.在人类感染中,对HIV-1包膜糖蛋白的广泛反应性抗体依赖性细胞毒性反应先于广泛中和反应出现。
Viral Immunol. 1991 Winter;4(4):215-23. doi: 10.1089/vim.1991.4.215.
6
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.人类体内缺乏针对人类免疫缺陷病毒感染细胞的细胞毒性抗体,以及在动物感染或用纯化包膜糖蛋白gp120免疫后诱导产生该抗体的情况。
Proc Natl Acad Sci U S A. 1987 Jun;84(11):3797-801. doi: 10.1073/pnas.84.11.3797.
7
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.用于检测人类免疫缺陷病毒中和抗体的简单、快速、定量、形成合胞体的微量测定法。
AIDS Res Hum Retroviruses. 1987 Fall;3(3):283-302. doi: 10.1089/aid.1987.3.283.
8
Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.尼日利亚伊巴丹孕妇血清中与1型和2型人类免疫缺陷病毒以及I型和II型人类嗜T淋巴细胞病毒血清学交叉反应的证据。
Int J Epidemiol. 1995 Feb;24(1):198-203. doi: 10.1093/ije/24.1.198.
9
Neutralizing antibodies and the course of HIV-induced disease.中和抗体与HIV诱发疾病的病程
AIDS Res Hum Retroviruses. 1987 Summer;3(2):157-63. doi: 10.1089/aid.1987.3.157.
10
Variable and conserved neutralization antigens of human immunodeficiency virus.人类免疫缺陷病毒的可变中和抗原与保守中和抗原
Nature. 1986;324(6097):572-5. doi: 10.1038/324572a0.

引用本文的文献

1
Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis.抗体依赖的增强作用(ADE)及补体系统在疾病发病机制中的作用。
Mol Immunol. 2022 Dec;152:172-182. doi: 10.1016/j.molimm.2022.11.010. Epub 2022 Nov 10.
2
Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.黏膜艾滋病病毒传播被早期感染时分离的抗病毒 IgG 增强。
AIDS. 2021 Dec 1;35(15):2423-2432. doi: 10.1097/QAD.0000000000003050.
3
Viral-Induced Enhanced Disease Illness.病毒诱导的加重疾病
Front Microbiol. 2018 Dec 5;9:2991. doi: 10.3389/fmicb.2018.02991. eCollection 2018.
4
Conserved HIV Epitopes for an Effective HIV Vaccine.用于有效HIV疫苗的保守HIV表位
J Clin Cell Immunol. 2017 Aug;8(4). doi: 10.4172/2155-9899.1000518. Epub 2017 Aug 30.
5
Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251.疫苗诱导的感染性病毒抗体捕获与猿猴免疫缺陷病毒SIVmac251反复低剂量直肠攻击后感染结果之间的关系
J Virol. 2016 Sep 12;90(19):8487-95. doi: 10.1128/JVI.00812-16. Print 2016 Oct 1.
6
Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users.VAX003 对注射吸毒者的 HIV-1 感染的低多发性和无疫苗增强作用。
Open Forum Infect Dis. 2014 Aug 14;1(2):ofu056. doi: 10.1093/ofid/ofu056. eCollection 2014 Sep.
7
Which Antibody Functions are Important for an HIV Vaccine?哪种抗体功能对于 HIV 疫苗很重要?
Front Immunol. 2014 Jun 18;5:289. doi: 10.3389/fimmu.2014.00289. eCollection 2014.
8
Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies.抗体介导的基于 Fcγ 受体的 HIV 抑制机制:最新发现和新的疫苗接种策略。
Viruses. 2009 Dec;1(3):1265-94. doi: 10.3390/v1031265. Epub 2009 Dec 15.
9
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement.一种通过补体靶向激活剂抑制HIV-1感染并增强HIV裂解的新方法。
Virol J. 2009 Aug 12;6:123. doi: 10.1186/1743-422X-6-123.
10
Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development.HIV感染中免疫系统增强抗体的“叛徒”:它们在HIV疫苗研发中的潜在意义
Vaccine. 2008 Jun 6;26(24):3078-85. doi: 10.1016/j.vaccine.2007.12.028. Epub 2008 Jan 10.